| Abbreviation | Full Form |
| SLE | Systemic lupus erythematosus |
| LN | Lupus nephritis |
| APO | Adverse pregnancy outcome |
| NLS | Neonatal lupus syndrome |
| aPL | Antiphospholipid antibodies |
| CHB | Complete heart block |
| NICU | Neonatal intensive care unit |
| IUGR | Intrauterine growth restriction |
| HELLPs | Hemolysis with elevated liver tests and low platelets |
| HCQ | Hydroxychloroquine |
| APS | Antiphospholipid syndrome |
| ANAs | Anti-nuclear antibodies |
| dsDNA | Double-stranded DNA |
| Th1 | T helper 1 cells |
| Th2 | T helper 2 cells |
| IL-10 | Interleukin-10 |
| IL-6 | Interleukin-6 |
| hCG | Human chorionic gonadotropin |
| PRL | Prolactin |
| IVIg | Intravenous immunoglobulin |
| RCTs | Randomized controlled trials |
| NOS | Newcastle–Ottawa scale |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PICOS | Population, Intervention, Comparison, Outcome, Study design |
| RC | Retrospective cohort study |
| PC | Prospective cohort study |
| CC | Case–control study |
| SRMA | Systematic review and meta-analysis |